Scenarios that move BEAM
Beam Therapeutics Inc. - Common Stock
Scenarios that move BEAM: 3 analyses, 2 positive, 1 negative.
- · Novartis acquires Abogen in $7.8B RNA therapeutics deal — ▲ · impact +14 · confidence low · horizon weeks
- · uniQure plunges after additional Huntington's disease study data — ▼ · impact -20 · confidence low · horizon weeks
- · ADARx Pharmaceuticals prices upsized $446.3 million initial public offering — ▲ · impact +55 · confidence low · horizon weeks